Ngā hua rapu - Yu‐Ning Wong

Whakamahine hua
  1. 1
    Evaluating Overall Survival and Competing Risks of Death in Patients With Localized Renal Cell Carcinoma Using a Comprehensive Nomogram

    Evaluating Overall Survival and Competing Risks of Death in Patients With Localized Renal Cell Carcinoma Using a Comprehensive Nomogram mā Alexander Kutikov, Brian L. Egleston, Yu‐Ning Wong, Robert G. Uzzo

    I whakaputaina 2009
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    National Study of Burnout and Career Satisfaction Among Physician Assistants in Oncology: Implications for Team-Based Care

    National Study of Burnout and Career Satisfaction Among Physician Assistants in Oncology: Implications for Team-Based Care mā Eric D. Tetzlaff, Heather M. Hylton, Lyudmila DeMora, Karen Ruth, Yu‐Ning Wong

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Trends in radical prostatectomy: centralization, robotics, and access to urologic cancer care

    Trends in radical prostatectomy: centralization, robotics, and access to urologic cancer care mā Karyn B. Stitzenberg, Yu‐Ning Wong, Matthew E. Nielsen, Brian L. Egleston, Robert G. Uzzo

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Histopathological Characteristics of Localized Renal Cell Carcinoma Correlate With Tumor Size: A SEER Analysis

    Histopathological Characteristics of Localized Renal Cell Carcinoma Correlate With Tumor Size: A SEER Analysis mā Jason Rothman, Brian L. Egleston, Yu‐Ning Wong, Kevan Iffrig, Steve Lebovitch, Robert G. Uzzo

    I whakaputaina 2008
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Predicting growth of solid renal masses under active surveillance

    Predicting growth of solid renal masses under active surveillance mā Paul L. Crispen, Yu‐Ning Wong, Richard E. Greenberg, David Y.T. Chen, Robert G. Uzzo

    I whakaputaina 2008
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Why Summary Comorbidity Measures Such As the Charlson Comorbidity Index and Elixhauser Score Work

    Why Summary Comorbidity Measures Such As the Charlson Comorbidity Index and Elixhauser Score Work mā Steven R. Austin, Yu‐Ning Wong, Robert G. Uzzo, J. Robert Beck, Brian L. Egleston

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    The Role of Primary Androgen Deprivation Therapy in Localized Prostate Cancer

    The Role of Primary Androgen Deprivation Therapy in Localized Prostate Cancer mā Yu‐Ning Wong, Stephen J. Freedland, Brian L. Egleston, Neha Vapiwala, Robert G. Uzzo, Katrina Armstrong

    I whakaputaina 2009
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Competing Risks of Death in Patients with Localized Renal Cell Carcinoma: A Comorbidity Based Model

    Competing Risks of Death in Patients with Localized Renal Cell Carcinoma: A Comorbidity Based Model mā Alexander Kutikov, Brian L. Egleston, Daniel Canter, Marc C. Smaldone, Yu‐Ning Wong, Robert G. Uzzo

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Metastatic Extramammary Paget’s Disease of Scrotum Responds Completely to Single Agent Trastuzumab in a Hemodialysis Patient: Case Report, Molecular Profiling and Brief Review of the Literature

    Metastatic Extramammary Paget’s Disease of Scrotum Responds Completely to Single Agent Trastuzumab in a Hemodialysis Patient: Case Report, Molecular Profiling and Brief Review of t... mā Peter Barth, Essel Dulaimi Al-Saleem, Kristin Edwards, Sherri Z. Millis, Yu‐Ning Wong, Daniel M. Geynisman

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Cost implications of new treatments for advanced colorectal cancer

    Cost implications of new treatments for advanced colorectal cancer mā Yu‐Ning Wong, Neal J. Meropol, William Speier, Daniel J. Sargent, Richard M. Goldberg, J. Robert Beck

    I whakaputaina 2009
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Age, Tumor Size and Relative Survival of Patients With Localized Renal Cell Carcinoma: A Surveillance, Epidemiology and End Results Analysis

    Age, Tumor Size and Relative Survival of Patients With Localized Renal Cell Carcinoma: A Surveillance, Epidemiology and End Results Analysis mā Benjamin Scoll, Yu‐Ning Wong, Brian L. Egleston, David A. Kunkle, Ismail R. Saad, Robert G. Uzzo

    I whakaputaina 2008
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Integration of prostate cancer clinical data using an ontology

    Integration of prostate cancer clinical data using an ontology mā Hua Min, Frank J. Manion, Elizabeth M. Goralczyk, Yu‐Ning Wong, Eric A. Ross, J. Robert Beck

    I whakaputaina 2009
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Role of Androgen Deprivation Therapy for Node-Positive Prostate Cancer

    Role of Androgen Deprivation Therapy for Node-Positive Prostate Cancer mā Yu‐Ning Wong, Stephen J. Freedland, Brian L. Egleston, Gary R. Hudes, J. Sanford Schwartz, Katrina Armstrong

    I whakaputaina 2008
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Survival among patients with advanced renal cell carcinoma in the pretargeted versus targeted therapy eras

    Survival among patients with advanced renal cell carcinoma in the pretargeted versus targeted therapy eras mā Pengxiang Li, Yu‐Ning Wong, Katrina Armstrong, Naomi B. Haas, Prasun Subedi, M. Davis-Cerone, Jalpa A. Doshi

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Inflammatory Breast Cancer Management in the National Comprehensive Cancer Network: The Disease, Recurrence Pattern, and Outcome

    Inflammatory Breast Cancer Management in the National Comprehensive Cancer Network: The Disease, Recurrence Pattern, and Outcome mā Jennifer M. Matro, Tianyu Li, Massimo Cristofanilli, Melissa E. Hughes, Rebecca A. Ottesen, Jane C. Weeks, Yu Ning Wong

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Advanced Imaging Modalities in Early Stage Breast Cancer: Preoperative Use in the United States Medicare Population

    Advanced Imaging Modalities in Early Stage Breast Cancer: Preoperative Use in the United States Medicare Population mā Margaret Lord Crivello, Karen Ruth, Elin R. Sigurdson, Brian L. Egleston, Kathryn Evers, Yu‐Ning Wong, Marcia Boraas, Richard J. Bleicher

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)‐positive breast cancer by race/ethnicity and education within the National Comprehensive Cancer Network

    Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)‐positive breast cancer by race/ethnicity and education within the National Comprehensive C... mā Rachel A. Freedman, Melissa E. Hughes, Rebecca A. Ottesen, Jane C. Weeks, Yulei He, Yu‐Ning Wong, Richard L. Theriault, Nancy L. Keating

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Preoperative Delays in the US Medicare Population With Breast Cancer

    Preoperative Delays in the US Medicare Population With Breast Cancer mā Richard J. Bleicher, Karen Ruth, Elin R. Sigurdson, Eric A. Ross, Yu‐Ning Wong, Sameer A. Patel, Marcia Boraas, Neal S. Topham, Brian L. Egleston

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Cost Concerns of Patients With Cancer

    Cost Concerns of Patients With Cancer mā Tammy K. Stump, Naa Eghan, Brian L. Egleston, Olivia Hamilton, Melanie Pirollo, J. Sanford Schwartz, Katrina Armstrong, J. Robert Beck, Neal J. Meropol, Yu-Ning Wong

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Phase I study of the mTOR inhibitor ridaforolimus and the HDAC inhibitor vorinostat in advanced renal cell carcinoma and other solid tumors

    Phase I study of the mTOR inhibitor ridaforolimus and the HDAC inhibitor vorinostat in advanced renal cell carcinoma and other solid tumors mā Matthew R. Zibelman, Yu‐Ning Wong, Karthik Devarajan, Lois Malizzia, Alycia Corrigan, Anthony J. Olszanski, Crystal S. Denlinger, Susan K. Roethke, Colleen H. Tetzlaff, Elizabeth R. Plimack

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: